glp-1 news nov 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care FDA bans compounded GLP-1 drugs

Weight Loss Drugs in Development Doctors are studying new treatment strategies to help people lose weight and to stay at a healthy weight

Int J Mol Med 2017;39:102936.ArticlePubMed 57

One final consideration is that as more states establish upper payment limit (UPL) setting authority either for prescription drug affordability boards or other similar entities, it becomes increasingly possible that GLP-1s could be subject to review and UPLs across various states

There is no physiological reason you cannot alternate between protocols

The ongoing evolution of basal insulin therapy over 100 years and its promise for the future

Oral tirzepatide is in clinical trials, and if successful, could eliminate the injection barrier entirely for this class